SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on June 28, 2002; DOI 10.1182/blood-2002-01-0278. This Article Full Text Full Text (PDF) All Versions of this Article: 2002-01-0278v1 100/7/2414    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Taniguchi, T. Articles by D'Andrea, A. D. Search for Related Content PubMed PubMed Citation Articles by Taniguchi, T. Articles by D'Andrea, A. D. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 October 2002, Vol. 100, No. 7, pp. 2414-2420 HEMATOPOIESIS S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51 Toshiyasu Taniguchi, Irene Garcia-Higuera, Paul R. Andreassen, Richard C. Gregory, Markus Grompe, and Alan D. D'Andrea From the Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; the Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA; and the Department of Molecular and Medical Genetics and Department of Pediatrics, Oregon Health Sciences University, Portland. Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and defective cell-cycle progression. Six FA genes (corresponding to subtypes A, C, D2, E, F, and G) have been cloned, and the encoded FA proteins interact in a common pathway. DNA damage activates this pathway, leading to monoubiquitination of the downstream FANCD2 protein and targeting to nuclear foci containing BRCA1. In the current study, we demonstrate that FANCD2 also undergoes monoubiquitination during S phase of the cell cycle. Monoubiquitinated FANCD2 colocalizes with BRCA1 and RAD51 in S-phase-specific nuclear foci. Monoubiquitination of FANCD2 is required for normal cell-cycle progression following cellular exposure to mitomycin C. Our data indicate that the monoubiquitination of FANCD2 is highly regulated, and they suggest that FANCD2/BRCA1 complexes and FANCD2/RAD51 complexes participate in an S-phase-specific cellular process, such as DNA repair by homologous recombination. © 2002 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: J. M. Kim, Y. Kee, A. Gurtan, and A. D. D'Andrea Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24 Blood, May 15, 2008; 111(10): 5215 - 5222. [Abstract] [Full Text] [PDF] J. L. Youds, L. J. Barber, J. D. Ward, S. J. Collis, N. J. O'Neil, S. J. Boulton, and A. M. Rose DOG-1 Is the Caenorhabditis elegans BRIP1/FANCJ Homologue and Functions in Interstrand Cross-Link Repair Mol. Cell. Biol., March 1, 2008; 28(5): 1470 - 1479. [Abstract] [Full Text] [PDF] N. Spardy, A. Duensing, D. Charles, N. Haines, T. Nakahara, P. F. Lambert, and S. Duensing The Human Papillomavirus Type 16 E7 Oncoprotein Activates the Fanconi Anemia (FA) Pathway and Causes Accelerated Chromosomal Instability in FA Cells J. Virol., December 1, 2007; 81(23): 13265 - 13270. [Abstract] [Full Text] [PDF] Y. Nomura, N. Adachi, and H. Koyama Human Mus81 and FANCB independently contribute to repair of DNA damage during replication Genes Cells, October 1, 2007; 12(10): 1111 - 1122. [Abstract] [Full Text] [PDF] C. Jacquemont and T. Taniguchi Proteasome Function Is Required for DNA Damage Response and Fanconi Anemia Pathway Activation Cancer Res., August 1, 2007; 67(15): 7395 - 7405. [Abstract] [Full Text] [PDF] J. M. Hinz, P. B. Nham, S. S. Urbin, I. M. Jones, and L. H. Thompson Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis Nucleic Acids Res., June 28, 2007; 35(11): 3733 - 3740. [Abstract] [Full Text] [PDF] A. Sobeck, S. Stone, and M. E. Hoatlin DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein FANCD2 Mol. Cell. Biol., June 15, 2007; 27(12): 4283 - 4292. [Abstract] [Full Text] [PDF] X. Wang, R. D. Kennedy, K. Ray, P. Stuckert, T. Ellenberger, and A. D. D'Andrea Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway Mol. Cell. Biol., April 15, 2007; 27(8): 3098 - 3108. [Abstract] [Full Text] [PDF] R. K. Nookala, S. Hussain, and L. Pellegrini Insights into Fanconi Anaemia from the structure of human FANCE Nucleic Acids Res., March 12, 2007; 35(5): 1638 - 1648. [Abstract] [Full Text] [PDF] E. Gallmeier, T. Hucl, J. R. Brody, D. A. Dezentje, K. Tahir, J. Kasparkova, V. Brabec, K. E. Bachman, and S. E. Kern High-Throughput Screening Identifies Novel Agents Eliciting Hypersensitivity in Fanconi Pathway-Deficient Cancer Cells Cancer Res., March 1, 2007; 67(5): 2169 - 2177. [Abstract] [Full Text] [PDF] S. Seki, M. Ohzeki, A. Uchida, S. Hirano, N. Matsushita, H. Kitao, T. Oda, T. Yamashita, N. Kashihara, A. Tsubahara, et al. A requirement of FancL and FancD2 monoubiquitination in DNA repair Genes Cells, March 1, 2007; 12(3): 299 - 310. [Abstract] [Full Text] [PDF] P. Kowal, A. M. Gurtan, P. Stuckert, A. D. D'Andrea, and T. Ellenberger Structural Determinants of Human FANCF Protein That Function in the Assembly of a DNA Damage Signaling Complex J. Biol. Chem., January 19, 2007; 282(3): 2047 - 2055. [Abstract] [Full Text] [PDF] F. Weber, Y. Xu, L. Zhang, A. Patocs, L. Shen, P. Platzer, and C. Eng Microenvironmental Genomic Alterations and Clinicopathological Behavior in Head and Neck Squamous Cell Carcinoma JAMA, January 10, 2007; 297(2): 187 - 195. [Abstract] [Full Text] [PDF] E. Gallmeier and S. E. Kern Targeting Fanconi Anemia/BRCA2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models Clin. Cancer Res., January 1, 2007; 13(1): 4 - 10. [Abstract] [Full Text] [PDF] Y. Wang and H. G. Dohlman Regulation of G Protein and Mitogen-Activated Protein Kinase Signaling by Ubiquitination: Insights From Model Organisms Circ. Res., December 8, 2006; 99(12): 1305 - 1314. [Abstract] [Full Text] [PDF] J. Dunn, M. Potter, A. Rees, and T. M. Runger Activation of the Fanconi Anemia/BRCA Pathway and Recombination Repair in the Cellular Response to Solar Ultraviolet Light Cancer Res., December 1, 2006; 66(23): 11140 - 11147. [Abstract] [Full Text] [PDF] Y. Wang, T. Wiltshire, J. Senft, S. L. Wenger, E. Reed, and W. Wang Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven Mol. Cancer Ther., December 1, 2006; 5(12): 3153 - 3161. [Abstract] [Full Text] [PDF] T. Pejovic, J. E. Yates, H. Y. Liu, L. E. Hays, Y. Akkari, Y. Torimaru, W. Keeble, R. K. Rathbun, W. H. Rodgers, A. E. Bale, et al. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res., September 15, 2006; 66(18): 9017 - 9025. [Abstract] [Full Text] [PDF] A. L. Medhurst, E. H. Laghmani, J. Steltenpool, M. Ferrer, C. Fontaine, J. de Groot, M. A. Rooimans, R. J. Scheper, A. R. Meetei, W. Wang, et al. Evidence for subcomplexes in the Fanconi anemia pathway Blood, September 15, 2006; 108(6): 2072 - 2080. [Abstract] [Full Text] [PDF] G. P. H. Ho, S. Margossian, T. Taniguchi, and A. D. D'Andrea Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance. Mol. Cell. Biol., September 1, 2006; 26(18): 7005 - 7015. [Abstract] [Full Text] [PDF] E. Barroso, R.L. Milne, L.P. Fernandez, P. Zamora, J.I. Arias, J. Benitez, and G. Ribas FANCD2 associated with sporadic breast cancer risk Carcinogenesis, September 1, 2006; 27(9): 1930 - 1937. [Abstract] [Full Text] [PDF] N. McCabe, N. C. Turner, C. J. Lord, K. Kluzek, A. Bialkowska, S. Swift, S. Giavara, M. J. O'Connor, A. N. Tutt, M. Z. Zdzienicka, et al. Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition Cancer Res., August 15, 2006; 66(16): 8109 - 8115. [Abstract] [Full Text] [PDF] R. D. Kennedy and A. D. D'Andrea DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes J. Clin. Oncol., August 10, 2006; 24(23): 3799 - 3808. [Abstract] [Full Text] [PDF] H. Kitao, K. Yamamoto, N. Matsushita, M. Ohzeki, M. Ishiai, and M. Takata Functional Interplay between BRCA2/FancD1 and FancC in DNA Repair J. Biol. Chem., July 28, 2006; 281(30): 21312 - 21320. [Abstract] [Full Text] [PDF] X. Yu, S. Fu, M. Lai, R. Baer, and J. Chen BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes & Dev., July 1, 2006; 20(13): 1721 - 1726. [Abstract] [Full Text] [PDF] W. Zhu and A. Dutta An ATR- and BRCA1-Mediated Fanconi Anemia Pathway Is Required for Activating the G2/M Checkpoint and DNA Damage Repair upon Rereplication Mol. Cell. Biol., June 15, 2006; 26(12): 4601 - 4611. [Abstract] [Full Text] [PDF] T. Taniguchi and A. D. D'Andrea Molecular pathogenesis of Fanconi anemia: recent progress Blood, June 1, 2006; 107(11): 4223 - 4233. [Abstract] [Full Text] [PDF] D. Chirnomas, T. Taniguchi, M. de la Vega, A. P. Vaidya, M. Vasserman, A.-R. Hartman, R. Kennedy, R. Foster, J. Mahoney, M. V. Seiden, et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol. Cancer Ther., April 1, 2006; 5(4): 952 - 961. [Abstract] [Full Text] [PDF] A. Sobeck, S. Stone, V. Costanzo, B. de Graaf, T. Reuter, J. de Winter, M. Wallisch, Y. Akkari, S. Olson, W. Wang, et al. Fanconi Anemia Proteins Are Required To Prevent Accumulation of Replication-Associated DNA Double-Strand Breaks Mol. Cell. Biol., January 15, 2006; 26(2): 425 - 437. [Abstract] [Full Text] [PDF] R. D. Kennedy and A. D. D'Andrea The Fanconi Anemia/BRCA pathway: new faces in the crowd Genes & Dev., December 15, 2005; 19(24): 2925 - 2940. [Abstract] [Full Text] [PDF] S. Houghtaling, A. Newell, Y. Akkari, T. Taniguchi, S. Olson, and M. Grompe Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining Hum. Mol. Genet., October 15, 2005; 14(20): 3027 - 3033. [Abstract] [Full Text] [PDF] J. Zhang and S. N. Powell The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair Mol. Cancer Res., October 1, 2005; 3(10): 531 - 539. [Abstract] [Full Text] [PDF] Y.-G. Yang, Z. Herceg, K. Nakanishi, I. Demuth, C. Piccoli, J. Michelon, G. Hildebrand, M. Jasin, M. Digweed, and Z.-Q. Wang The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells Carcinogenesis, October 1, 2005; 26(10): 1731 - 1740. [Abstract] [Full Text] [PDF] K. M. Austin, R. J. Leary, and A. Shimamura The Shwachman-Diamond SBDS protein localizes to the nucleolus Blood, August 15, 2005; 106(4): 1253 - 1258. [Abstract] [Full Text] [PDF] Q. Chen, P. C. Van der Sluis, D. Boulware, L. A. Hazlehurst, and W. S. Dalton The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells Blood, July 15, 2005; 106(2): 698 - 705. [Abstract] [Full Text] [PDF] W.-H. Park, S. Margossian, A. A. Horwitz, A. M. Simons, A. D. D'Andrea, and J. D. Parvin Direct DNA Binding Activity of the Fanconi Anemia D2 Protein J. Biol. Chem., June 24, 2005; 280(25): 23593 - 23598. [Abstract] [Full Text] [PDF] S. Eladad, T.-Z. Ye, P. Hu, M. Leversha, S. Beresten, M. J. Matunis, and N. A. Ellis Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification Hum. Mol. Genet., May 15, 2005; 14(10): 1351 - 1365. [Abstract] [Full Text] [PDF] N. G. Howlett, T. Taniguchi, S. G. Durkin, A. D. D'Andrea, and T. W. Glover The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability Hum. Mol. Genet., March 1, 2005; 14(5): 693 - 701. [Abstract] [Full Text] [PDF] R. Montes de Oca, P. R. Andreassen, S. P. Margossian, R. C. Gregory, T. Taniguchi, X. Wang, S. Houghtaling, M. Grompe, and A. D. D'Andrea Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin Blood, February 1, 2005; 105(3): 1003 - 1009. [Abstract] [Full Text] [PDF] J. Mi and G. M. Kupfer The Fanconi anemia core complex associates with chromatin during S phase Blood, January 15, 2005; 105(2): 759 - 766. [Abstract] [Full Text] [PDF] K. Yamamoto, S. Hirano, M. Ishiai, K. Morishima, H. Kitao, K. Namikoshi, M. Kimura, N. Matsushita, H. Arakawa, J.-M. Buerstedde, et al. Fanconi Anemia Protein FANCD2 Promotes Immunoglobulin Gene Conversion and DNA Repair through a Mechanism Related to Homologous Recombination Mol. Cell. Biol., January 1, 2005; 25(1): 34 - 43. [Abstract] [Full Text] [PDF] S. Houghtaling, L. Granville, Y. Akkari, Y. Torimaru, S. Olson, M. Finegold, and M. Grompe Heterozygosity for p53 (Trp53+/-) Accelerates Epithelial Tumor Formation in Fanconi Anemia Complementation Group D2 (Fancd2) Knockout Mice Cancer Res., January 1, 2005; 65(1): 85 - 91. [Abstract] [Full Text] [PDF]